Colgate-Palmolive Reaches New 52-Week High (CL)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Colgate-Palmolive Company (NYSE: CL) hit a new 52-week high Tuesday as it is currently trading at $122.42, above its previous 52-week high of $122.40 with 511,638 shares traded as of 11:56 a.m. ET. Average volume has been 1.6 million shares over the past 30 days.

Colgate-Palmolive has a market cap of $56.3 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 15.7% year to date as of the close of trading on Monday.

Colgate-Palmolive Company, together with its subsidiaries, manufactures and markets consumer products worldwide. The company operates in two segments: Oral, Personal and Home Care; and Pet Nutrition. The company has a P/E ratio of 24.7, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Colgate-Palmolive as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Colgate-Palmolive Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.
null

If you liked this article you might like

With Eyes on Solar Eclipse, Wall Street Stumbles Yet Again

Unilever Bankers Said to Be Pushing for Colgate-Palmolive Takeover